Education
About Us
Working with TipRanks
Follow Us
Q BioMed Inc (QBIO)
OTHER OTC:QBIO
Total Valuation
Q BioMed has a market cap or net worth of $14.51K. The enterprise value is ―.
Market Cap$14.51K
Enterprise Value―
Share Statistics
Q BioMed has 145,094,530 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding145,094,530
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Q BioMed’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee94.78K
Profits Per Employee-684.03K
Employee Count3
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Q BioMed is ―. Q BioMed’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Q BioMed had revenue of 284.35K and earned -2.05M in profits. Earnings per share was -0.08.
Revenue284.35K
Gross Profit-8.99K
Operating Income-3.45M
Pretax Income-2.05M
Net Income-2.05M
EBITDA-617.63K
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was 2.53M and capital expenditures 0.00, giving a free cash flow of 2.53M billion.
Operating Cash Flow2.53M
Free Cash Flow2.53M
Free Cash Flow per Share0.02
Dividends & Yields
Q BioMed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta104.54
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)37.40K
Important Dates
Q BioMed upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Q BioMed as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Q BioMed has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Q BioMed EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Q BioMed has $0.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $0.00 billion.
Cash & Marketable Securities$0.00
Total Debt$0.00
Net Cash$0.00
Net Cash Per Share$0.00
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Q BioMed is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―